Detalles de la búsqueda
1.
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.
Ann Hematol
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695872
2.
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.
J Clin Invest
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833312
3.
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity.
Front Immunol
; 13: 1058126, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726971
4.
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience.
Cancers (Basel)
; 13(19)2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638273
5.
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
PLoS One
; 12(7): e0181508, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28742866
6.
Global transcriptome analysis reveals small RNAs affecting Neisseria meningitidis bacteremia.
PLoS One
; 10(5): e0126325, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25951061
Resultados
1 -
6
de 6
1
Próxima >
>>